Imiquimod

Overview

An agonist of TLR7 with immune response modifying activity, Approved for basal cell carcinoma, In Phase III for VIN and CIN, Imiquimod's proapoptotic activity appears to be related to Bcl-2 overexpression in susceptible tumor cells.

Application

Products > Drug Discovery > Impurities > Dermatology > Imiquimod and Impurities | Products > Drug Discovery > Inhibitor

Product Information

• Catalog No.: B2693-080488
• CAS No.: 99011-02-6
• Molecular Formula: C14H16N4
• Molecular Weight: 240.30
• Purity: >98%
• Storage: Store at -20°C
• Solubility: Soluble in Aqueous Acid (Slightly), DMSO (Very Slightly, Heated)

Source

Original product source